XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Segment Reporting SEGMENT REPORTING
Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision-maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. Our CODM is our Chief Executive Officer. Our reportable segments include diagnostic and information technology-based products and services for the veterinary sector, which we refer to as the Companion Animal Group (“CAG”), water quality products (“Water”) and diagnostic products and services for livestock and poultry health and to ensure the quality and safety of milk and improve producer efficiency, which we refer to as Livestock, Poultry and Dairy (“LPD”). Although our LPD segment does not meet the quantitative thresholds to be reported as a separate segment, we believe it is important to disaggregate these revenues as a major product and service category within our Other reportable segment given its distinct markets, and therefore we have elected to report LPD as a reportable segment. Our Other operating segment combines and presents products and services for the human medical diagnostics sector with our out-licensing arrangements. Assets are not allocated to segments for internal reporting purposes.

The following is a summary of segment performance:
(in thousands)For the Three Months Ended March 31,
CAGWaterLPDOtherConsolidated Total
2022
Revenue$761,184 $36,371 $30,870 $8,124 $836,549 
Income from operations$223,125 $16,654 $6,737 $1,828 $248,344 
Interest expense, net(6,853)
Income before provision for income taxes241,491 
Provision for income taxes47,526 
Net income193,965 
Less: Net income attributable to noncontrolling interest— 
Net income attributable to IDEXX Laboratories, Inc. stockholders$193,965 
2021
Revenue$692,767 $34,040 $39,270 $11,630 $777,707 
Income from operations$213,210 $14,772 $13,808 $5,832 $247,622 
Interest expense, net(7,532)
Income before provision for income taxes240,090 
Provision for income taxes35,801 
Net income204,289 
Less: Net income attributable to noncontrolling interest32 
Net income attributable to IDEXX Laboratories, Inc. stockholders$204,257 
Refer to “Note 3. Revenue Recognition” for a summary of disaggregated revenue by reportable segment and by major product and service category for the three months ended March 31, 2022 and 2021.